Marshall Wace’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.91M Buy
368,950
+157,202
+74% +$2.94M 0.01% 904
2025
Q1
$3.81M Buy
+211,748
New +$3.81M ﹤0.01% 1110
2024
Q2
Sell
-43,856
Closed -$649K 2625
2024
Q1
$649K Buy
+43,856
New +$649K ﹤0.01% 1605
2023
Q4
Sell
-3,602
Closed -$38.9K 2219
2023
Q3
$38.9K Buy
+3,602
New +$38.9K ﹤0.01% 1769
2023
Q2
Sell
-17,273
Closed -$228K 2440
2023
Q1
$228K Buy
+17,273
New +$228K ﹤0.01% 1895
2021
Q4
Sell
-6,922
Closed -$251K 3517
2021
Q3
$251K Buy
+6,922
New +$251K ﹤0.01% 2134
2020
Q3
Sell
-2,730
Closed -$50K 1837
2020
Q2
$50K Buy
+2,730
New +$50K ﹤0.01% 1448
2019
Q4
Sell
-70,903
Closed -$1.33M 1950
2019
Q3
$1.33M Sell
70,903
-53,753
-43% -$1.01M 0.01% 834
2019
Q2
$3.25M Buy
124,656
+10,016
+9% +$261K 0.03% 604
2019
Q1
$2.95M Buy
114,640
+81,023
+241% +$2.08M 0.03% 630
2018
Q4
$773K Buy
33,617
+20,277
+152% +$466K 0.01% 979
2018
Q3
$428K Buy
13,340
+10,949
+458% +$351K ﹤0.01% 953
2018
Q2
$68K Buy
+2,391
New +$68K ﹤0.01% 676
2017
Q1
Sell
-13,705
Closed -$326K 671
2016
Q4
$326K Sell
13,705
-7,146
-34% -$170K ﹤0.01% 876
2016
Q3
$765K Buy
+20,851
New +$765K 0.01% 753
2016
Q2
Sell
-84,793
Closed -$1.76M 1124
2016
Q1
$1.76M Buy
84,793
+12,180
+17% +$253K 0.02% 589
2015
Q4
$2.2M Hold
72,613
0.02% 547
2015
Q3
$1.79M Buy
72,613
+2,874
+4% +$71K 0.02% 480
2015
Q2
$2.24M Buy
69,739
+12,444
+22% +$400K 0.03% 456
2015
Q1
$2.05M Buy
57,295
+20,943
+58% +$748K 0.03% 464
2014
Q4
$825K Buy
+36,352
New +$825K 0.01% 594
2014
Q3
Sell
-17,976
Closed -$653K 1015
2014
Q2
$653K Buy
+17,976
New +$653K 0.01% 567